Sini Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 21-12-2024
- Paid Up Capital ₹ 0.10 M
as on 21-12-2024
- Company Age 3 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
About Sini Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Siddharth Patel, Yashvant Patel, Nisarg Patel, and One other member serve as directors at the Company.
- CIN/LLPIN
U24299GJ2021PTC125950
- Company No.
125950
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Sep 2021
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media
Who are the key members and board of directors at Sini Pharma?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nisarg Patel  | Director | 29-Sep-2021 | Current |
| Siddharth Patel | Director | 29-Sep-2021 | Current |
| Yashvant Patel | Director | 29-Sep-2021 | Current |
| Maheshkumar Patel | Director | 29-Sep-2021 | Current |
Financial Performance of Sini Pharma.
Sini Pharma Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Sini Pharma?
Unlock access to Sini Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Aetos Pharma Private LimitedActive 3 years 3 monthsNisarg Patel and Maheshkumar Patel are mutual person
Sini Brook Biotech Private LimitedActive 2 years 10 monthsSiddharth Patel, Yashvant Patel and 2 more are mutual person
- Serifos Pharma Private LimitedActive 2 years 8 months
Siddharth Patel and Nisarg Patel are mutual person
- Sidmex Inovia Private LimitedActive 5 months 13 days
Siddharth Patel and Yashvant Patel are mutual person
- Blue Lotus Luxury Homes LlpActive 7 years 4 months
Nisarg Patel and Maheshkumar Patel are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sini Pharma?
Sini Pharma has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sini Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sini Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
